跳转至内容
Merck
CN
  • RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development.

RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development.

eLife (2020-10-08)
Renaud Mevel, Ivana Steiner, Susan Mason, Laura Ca Galbraith, Rahima Patel, Muhammad Zh Fadlullah, Imran Ahmad, Hing Y Leung, Pedro Oliveira, Karen Blyth, Esther Baena, Georges Lacaud
摘要

The characterization of prostate epithelial hierarchy and lineage heterogeneity is critical to understand its regenerative properties and malignancies. Here, we report that the transcription factor RUNX1 marks a specific subpopulation of proximal luminal cells (PLCs), enriched in the periurethral region of the developing and adult mouse prostate, and distinct from the previously identified NKX3.1+ luminal castration-resistant cells. Using scRNA-seq profiling and genetic lineage tracing, we show that RUNX1+ PLCs are unaffected by androgen deprivation, and do not contribute to the regeneration of the distal luminal compartments. Furthermore, we demonstrate that a transcriptionally similar RUNX1+ population emerges at the onset of embryonic prostate specification to populate the proximal region of the ducts. Collectively, our results reveal that RUNX1+ PLCs is an intrinsic castration-resistant and self-sustained lineage that emerges early during prostate development and provide new insights into the lineage relationships of the prostate epithelium.

材料
货号
品牌
产品描述

Sigma-Aldrich
泰莫西芬, ≥99%
Sigma-Aldrich
双氢睾酮-2,3,4-13C3 溶液, 0.1 mg/mL in methanol, 99 atom % 13C, 97% (CP)
Supelco
4-羟基他莫西芬, analytical standard, (E) and (Z) isomers (50:50)